Allergy and Immunology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Pediatrics, Umm Al-Qura University College of Medicine, Makkah, Saudi Arabia
BMJ Case Rep. 2022 Jun 22;15(6):e249254. doi: 10.1136/bcr-2022-249254.
Barth syndrome (BTHS) is an X linked recessive disorder caused by a mutation in the tafazzin (TAZ) gene classically associated with the triad of neutropaenia and cardiac and skeletal myopathies. Here we present a case of BTHS in a 2-month-old male patient found to have a novel variant of the TAZ gene (hemizygous c.639G>A) leading to early termination of the tafazzin protein (p.Trp213Ter) with presumed loss of function. Our patient was found to have dilated cardiomyopathy, cyclic neutropaenia and growth delays, which in combination with genetic work-up confirmed the diagnosis of BTHS. He also experienced repeated bacterial and viral infections, prompting an immunological work-up which revealed persistent B cell lymphopaenia and hypogammaglobulinaemia. He ultimately required subcutaneous immunoglobulin replacement and GM-CSF for ongoing hypogammaglobulinaemia and neutropaenia. To our knowledge, this case is the first report of BTHS associated with B cell lymphopaenia and hypogammaglobulinaemia.
巴德-希利综合征(BTHS)是一种 X 连锁隐性遗传病,由tafazzin(TAZ)基因突变引起,经典三联征包括中性粒细胞减少症、心肌和骨骼肌疾病。本文报道了 1 例 2 月龄男性 BTHS 患者,携带 TAZ 基因的新型变异(杂合子 c.639G>A),导致 tafazzin 蛋白提前终止(p.Trp213Ter),推测其功能丧失。该患者被诊断为 BTHS,表现为扩张型心肌病、周期性中性粒细胞减少和生长迟缓,结合遗传学检查结果。此外,他还反复发生细菌和病毒感染,进一步进行免疫学检查发现持续的 B 细胞淋巴细胞减少和低丙种球蛋白血症。最终,他需要接受皮下免疫球蛋白替代治疗和 GM-CSF 治疗以维持低丙种球蛋白血症和中性粒细胞减少症。据我们所知,该病例是首例报道的与 B 细胞淋巴细胞减少和低丙种球蛋白血症相关的 BTHS。